Acrivon Therapeutics (NasdaqGM:ACRV) 2026 Earnings Call Presentation

Acrivon T h e r a p e u t i c s Acrivon T h e r a p e u t i c s KOL PANEL DISCUSSION ACR-368 ENDOMETRIAL C ANCER TRIAL Certain information contained in this presentation and related webcast includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding our future results of operations or financial condition, business strategy and plans and objectives of management for future operations. In some cases, you can identify forward-looking statements becau ...